Upadacitinib for Non-Radiographic Axial Spondyloarthritis User Reviews
Brand names: Rinvoq
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about upadacitinib
- Check interactions
- Compare alternatives
- Reviews (174)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
- En español
Rinvoq (upadacitinib) "I noticed less pain in my SI joints and hip after 4 weeks. After 12 weeks, I had about 70-80% improvement. I basically had no side effects. However, after about 6 months on Rinvoq, my Sed Rate increased from 6 to 24, and I started having more pain and sciatica. Not sure why I have had such a lengthy and severe flare-up."